Research Article: Dapagliflozin Improves Erythropoiesis and Iron Metabolism in Type Diabetic Patients with Renal Anemia
Introduction:
Due to age-related decline in renal function, the proportion of chronic kidney disease (CKD) patients is increasing among the elderly. Anemia is an independent risk factor for the development and progression of both cardiovascular disease (CVD) and CKD in elderly patients with CKD and/or heart failure (HF). The triad of HF, CKD, and anemia is known as cardiorenal anemia syndrome, in which heart disease, kidney disease, and anemia interact in a vicious circle. The management of anemia in CKD consists of iron…
Read more